Sign up to save your podcasts
Or
Share Episode 22 - IL13R antagonist for chronic itch developed in Singapore; and a chat with Prof Tan Suat Hoon
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 22 - IL13R antagonist for chronic itch developed in Singapore; and a chat with Prof Tan Suat Hoon
Sashen and I discuss Eblasakimab, a new-in-class biologic agent that may potentially address chronic itch in atopic dermatitis. Then I speak with Prof Tan Suat Hoon, Director of the National Skin Centre, about lessons learnt from the pandemic, and the upcoming New Building for NSC, and future of dermatology clinical care in Singapore.
**Addendum: Prof Tan referred to the SARS outbreak in 2013, she meant 2003.
Online registration for the WCD 2023 is now open! https://www.wcd2023singapore.org/registration/
And we are also accepting abstract submissions: https://www.wcd2023singapore.org/scientific-programme/abstract-submission/
View all episodes
By Etienne WangSashen and I discuss Eblasakimab, a new-in-class biologic agent that may potentially address chronic itch in atopic dermatitis. Then I speak with Prof Tan Suat Hoon, Director of the National Skin Centre, about lessons learnt from the pandemic, and the upcoming New Building for NSC, and future of dermatology clinical care in Singapore.
**Addendum: Prof Tan referred to the SARS outbreak in 2013, she meant 2003.
Online registration for the WCD 2023 is now open! https://www.wcd2023singapore.org/registration/
And we are also accepting abstract submissions: https://www.wcd2023singapore.org/scientific-programme/abstract-submission/